share_log

Maxim Group Upgrades Palisade Bio to Buy, Announces $50 Price Target

Maxim Group Upgrades Palisade Bio to Buy, Announces $50 Price Target

Maxim集团将Palisade Bio上调为买入,宣布目标股价为50美元
Benzinga ·  2023/03/30 09:22

Maxim Group analyst Naz Rahman upgrades Palisade Bio (NASDAQ:PALI) from Hold to Buy and announces $50 price target.

Maxim集团分析师纳兹·拉赫曼将Palisade Bio(纳斯达克股票代码:PALI)从持有上调至买入,并宣布了50美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发